TheEdgeResearch
Home / Stocks / MDIN

MedGen, Inc. (MDIN)

OTC Healthcare Medical - Pharmaceuticals
$0.00 ▲ +0.00%
Market Cap
$90,309
Sector
Healthcare
Industry
Medical - Pharmaceuticals
Beta
0.89
52-Wk Range
0.000001-0.00003
CEO
Adir Iakya
Country
CA
Currency
USD

MedGen, Inc. operates in the Medical - Pharmaceuticals industry of the Healthcare sector, headquartered in Winnipeg, MB, CA. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $90,309. On trailing twelve-month figures it carries a trailing P/E of -600.00, a net margin of 0.0%. Its beta of 0.89 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
-600.00
Price / Sales
0.00
Price / Book
-217.64
EV / EBITDA
-5875.73
Gross margin
0.0%
Operating margin
0.0%
Net margin
0.0%
Return on equity
Debt / equity
-0.57
Current ratio
0.00
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
3
IPO date
2003-02-03
Headquarters
Winnipeg, MB, CA
About MedGen, Inc.

On June 25, 2020, MedGen, Inc. acquired 9430075 Canada Ltd. through a reverse merger transaction. Founded in 2015 and based in Winnipeg, Canada, 9430075 Canada Ltd. manages a digital health and wellness platform. This platform serves two primary functions: it assists individuals in finding vital health information and referrals, and it allows health and wellness professionals to directly engage with clients.

Comparable companies

MedGen, Inc. is most often compared with the following Healthcare names:

AREVFCHNXFHMPQINQDLFCOFPDMIRASPTEVNFVIVXFWSNAF
More research on MDIN
MDIN technical analysis MDIN TheEdge Score Compare against peers
Open full interactive analysis & DCF →